Overview

In the pharmaceutical industry, monitoring and assessing adverse events (AEs) or adverse drug reactions (ADRs) is critical to ensure patient safety and the effectiveness of medical treatments. However, the ever-increasing volume and diversity of data sources, ranging from handwritten notes to structured reports, have presented notable challenges to traditional pharmacovigilance (PV) processes.

Our differentiated, automated and intelligent case intake system seamlessly ingests data from various sources, such as handwritten notes, faxes, emails, PDFs, word documents, literature and both structured and unstructured formats. It goes beyond simple ingestion by automating the extraction of essential information, validating case reports, prioritizing them, generating narratives and auto-coding medical terms using MedDRA and medicinal products using WHO DD (drug dictionary).

Enhanced efficiency

Significantly reduces manual effort, speeding up case intake

Improved data quality

Minimizes errors associated with manual data entry

Reduced compliance risks

Ensures adherence to global pharmacovigilance standards

Cost savings

Optimizes resource allocation and operational costs

Faster decision-making

Enables timely identification and response to safety concerns